Hong Kong's first Zika case tests negative
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Workers from the Food and Environmental Hygiene Department kill mosquitoes outside a construction site near a residential area in Hong Kong, China August 26, 2016, after the first case of Zika was confirmed in the city. REUTERS/Bobby Yip
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
HONG KONG (Reuters) - Hong Kong's first Zika patient tested negative for the virus on Friday and was discharged from hospital, the government said in a statement.
On Thursday, the Centre for Health Protection had said the 38-year-old woman, who had returned to Hong Kong after spending two weeks in in the Caribbean, had tested positive.
She was initially tested and admitted to hospital after suffering symptoms of joint pain and red eyes.
The statement issued late on Friday said laboratory testing of the patient's blood and urine showed negative results for the virus. It did not explain the discrepancy with results of the earlier test.
Zika was detected in Brazil last year and has since spread across the Americas. The virus poses a risk to pregnant women because it can cause severe birth defects. It has been linked to more than 1,800 cases of microcephaly in Brazil.
(Reporting by Michelle Chen; Editing by Simon Cameron-Moore)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIA says Russia intervened to help Trump win White House
- Murdoch's new Sky bid should be probed says former UK minister
- France seeks to extend state of emergency until July - PM Cazeneuve
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!